Merck partners with Susan G. Komen for the Cure on historic initiative to help address cervical and breast cancer in developing nations
The initiative will support disease education, screening and treatment efforts as well as increased access to cervical cancer vaccination. This contribution is in addition to Merck's commitment to support a national cervical cancer vaccination program in Tanzania, which will soon be initiated by the Ministry of Health. Merck is a founding corporate partner of the Pink Ribbon–Red Ribbon initiative.




